Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Anil Kapur Insider Profile
4 Followers
Anil Kapur, Chief Commercial Officer at Actinium Pharmaceuticals, holds ― shares in Actinium Pharmaceuticals (Ticker: ATNM), holds 60.78K shares in Geron (Ticker: GERN), holds ― shares in Verastem (Ticker: VSTM). Most recently, Anil Kapur ― shares of Actinium Pharmaceuticals on ― for an estimated value of ―.
Anil Kapur has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Anil Kapur holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Anil Kapur
Anil Kapur's Trading History
Actinium Pharmaceuticals
―
Chief Commercial Officer
―
―
Geron
Jun 30, 2023
EVP, CORP STRATEGY & CCO
Uninformative Buy
15.44K
$238.88K
Verastem
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Anil Kapur's performance on stock
You May Also Like
Anil Kapur insider profile FAQ
What is the percentage of profitable transactions made by Anil Kapur?
The percentage of profitable transactions made by Anil Kapur is ―.
What is the average return per transaction made by Anil Kapur?
The average return per transaction made by Anil Kapur is ―.
What stocks does Anil Kapur hold?
Anil Kapur holds: ATNM, GERN, VSTM stocks.
What was Anil Kapur’s latest transaction?
Anil Kapur latest transaction was an Uninformative Buy of ―.
What was Anil Kapur's most profitable transaction?
Anil Kapur’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Anil Kapur's role in Actinium Pharmaceuticals?
Anil Kapur's role in Actinium Pharmaceuticals is Chief Commercial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.